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SUMMARY Percutaneous transhepatic biliary decompression 
is a preoperative surgical adjunct in patients with obstructive 
jaundice that has been in use since 1973. It is recommended 
that this procedure be adopted for both palliative treatment in 
unresectable patients and as a preoperative means of lowering 
serum bilirubin in patients with potentially resectable malignan-
cies of the pancreas or biliary tract. Metastatic tumor seeding 
along the transhepatic biliary catheter is an unusual complica-
tion resulting from this procedure but there have been a few 
cases reported in the literature. Below is a report on a 59-year-
old woman in whom the percutaneous transhepatic catheter 
drainage of the biliary tree, performed before surgical resection 
of a cholangiocarcinoma, caused cutaneous tumor implanta-
tion at the catheter site 3 months later. The clinical aspect was 
morphea-like and histopathologic examination revealed typical 
features of a dermal metastasis of adenocarcinoma. Immuno-
histochemistry revealed cytoplasmic positivity for cytokeratin 
7-19, specific for the biliary tract epithelium. A review of the lit-
erature available led us to conclude that port-site metastasis 
in patients with obstructive jaundice treated with percutaneous 
transhepatic biliary decompression was an unusual but possible 
complication. In fact, many catheter-tract metastatic deposits in 
the liver parenchyma, detected at autopsy or on operation, are 
mistakenly identified as hematogenous or lymphatic metastasis 
and are not attributed to a catheter-related process. We also 
report on this case because of the atypical morphea-like aspect 
of the skin metastasis. 
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 Percutaneous transhepatic biliary drainage 
(PTBD) has become an established and effec-
tive method of treatment for malignant obstruc-
tive jaundice. Although PTBD is considered safe, 
the procedure is not entirely free of complica-
tions, which include bile peritonitis, cholangitis, 
catheter dislocation, or hemorrhage. Metastatic 
tumor seeding along the transhepatic biliary cath-
eter is a very rare complication and until now 
there have been very few reported cases (1). 
Acta Dermatovenerol Croat  2005;13(2):118-121 CASE REPORT
118
ACTA DERMATOVENEROLOGICA CROATICA
 We recently treated a patient in whom percu-
taneous biliary drainage was employed before an 
operation, and which resulted in an atypical cu-
taneous morphea-like tumor implantation at the 
catheter site 2 months later. This led us to discuss 
“the theories and the realities” of port-site metas-
tasis and the usefulness of percutaneous transhe-
patic biliary decompression.
CASE REPORT
 In October 2001, a 59-year-old woman was 
admitted to the Department of Dermatology and 
Plastic Surgery of the La Sapienza University of 
Rome, with a morphea-like plaque involving the 
mesogastric region. The lesion was localized near 
a surgical scar (Fig. 1). Her past medical history 
included hypertension that had been treated with 
Ca-antagonists from 1990. On January 15, 2001, 
she was admitted to the Rome Medical Hospital 
for malaise and jaundice. Examinations including 
computed tomography (CT) scanning and ultra-
sonography (US) of the abdomen revealed a tu-
mor mass in the enhanced common bile duct. To-
tal bilirubin at the time of admission was 8.5 mg/dl. 
On January 16, 2001, PTBD was performed and 
the total bilirubin level decreased to normal. On 
February 1, 2001, the patient underwent PTBD 
with type II reconstruction and no evidence of liver 
metastasis or intra-abdominal spread of the neo-
plasm was found. The final histologic diagnosis 
was cholangiocarcinoma of the common bile duct. 
No metastasis was found in the resected lymph 
nodes. After the operation, the patient was given 
chemotherapy treatment consisting of 200 mg/day 
of 5-fluorouracil intravenously for 10 days and 10 
mg/day of cisplatin intravenously for 10 days, and 
the patient was discharged on the postoperative 
Figure 1. A morphea-like plaque involving the 
mesogastric region near surgical scar.
day 40. In April 2001, the patient developed an 
erythematous macule which had subsequently en-
larged as a nodule that underwent a sclerotizing 
process at the skin site of PTBD. Physical exami-
nation revealed a sclerotic plaque measuring 2.5 
to 3 cm in diameter in the mesogastric region. The 
lesion was red in color with a well circumscribed 
border, and it was near the surgical scar. 
 A biopsy specimen of the lesion was obtained. 
Histologically, the lesion showed dermal adeno-
carcinomatous infiltration of epithelial neoplastic 
cells, organized in ducts and cords and occa-
sionally forming mucinous lakes (Fig. 2). At high 
power, the abnormal shape and size of the epi-
thelial cells were very evident. Areas of sclerosis 
of the stroma with hypertrophic collagen bundles 
were occasionally observed (Fig. 3); they were re-
sponsible for the clinical aspect of the lesion. The 
positivity for cytokeratins 7 and 19 revealed the 
biliary derivation of the neoplastic epithelial cells 
(Fig. 4). The lesion was completely excised under 
local anesthesia. The patient was re-examined at 
3-month intervals for one year, with no evidence of 
recurrence so far. 
DISCUSSION 
 In 1973, Molnar and Stockum presented the first 
reported series (2), in which PTBD was used as a 
diagnostic and therapeutic procedure in patients 
with obstructive jaundice. Several subsequent 
Figure 2.   A dermal adenocarcinomatous infiltra- 
tion of epithelial neoplastic cells, organized in 
ducts and cords. 
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reports suggested that this procedure, by improv-
ing hepatic function before an operation, could 
reduce the postoperative incidence of morbidity 
and mortality in patients with hyperbilirubinemia, 
and its use was recommended as a preoperative 
adjunct in patients with both benign and malignant 
disease. However, these retrospective studies 
compared sequential groups of patients with and 
without preoperative drainage (3,4). Major compli-
cations of PTBD include bacteremia, septicemia, 
hemorrhage (0.2%), catheter dislocation (5%), 
and bile leak with or without peritonitis (3%). Minor 
complications include periprocedural pain (2%-
20%), incomplete catheter dislocation (5%-18%), 
catheter obstruction (3%-27%) and pneumothorax 
(0.5%). Bacteremia and septicemia occur in 12%-
47% of patients, but they are reduced significantly 
by the preprocedural use of antibiotics (5-6).  
 Implantation metastasis is another possible 
complication which has been documented in 19 
patients in the literature (including this case re-
port) (1).
 How can we explain the port site metastases in 
these cases and in our patient? There are a few 
theories: (a) transfer of tumor cells; (b) the effect 
of the pneumoperitoneum on tumor growth; and 
(c) perineural tumor growth (7). 
a) Tumor cells may theoretically arrive at the tro-
car wounds by direct contact, indirect spread, 
or by hematogeneous route. One report states 
that during a fine-needle aspiration biopsy, ap-
proximately 1,000 cells can be seeded along 
the needle track (8). Direct contamination of the 
wounds by the tumor cell-carrying instruments 
or direct contact of the wounds with the tumor 
specimen is the most probable way.
b) Classic experiments by Eggermont et al. 
showed that laparotomy stimulated subcutane-
ous tumor growth due to a direct depressant 
effect of the operative system on the immune 
system (9).
c) A third possible way is tumor cell growth along 
the tract similar to perineural tumor growth.
In the light of these considerations, we believe 
that, as reported in the literature, many catheter-
tract metastatic deposits are detected at autopsy 
but are mistakenly identified as arising from a he-
matogenous or lymphatic source and are not at-
tributed to a catheter-related process.
 We also report on this case because of the 
unusual clinical morphea-like manifestation. Clini-
cally, a sclerotic plaque may suggest an annular 
granuloma, morphea, sclero-atrophy scar or a 
xanthogranuloma. In fact, most cutaneous me-
tastases arise as nonspecific painless dermal or 
subcutaneous nodules with an intact, overlying 
epidermis. The most common clinical finding are 
clusters of discrete, firm, painless nodules emerg-
ing rapidly without explanation at a given anatomic 
site, which proliferate rapidly and then remain sta-
tionary (10).
 We also report the long survival of our patient: 
cutaneous metastases still have a poor progno-
sis, especially in patients with cancer of the lung, 
ovary, upper respiratory tract and, as in our case, 
upper digestive tract.
In conclusion, we report on this case because we 
believe that the incidence of implantation metas-
tases after fine-needle procedures is probably un-
derestimated: we do not recommend that invasive 
techniques be abandoned, but we would simply 
like to warn of their rare but real risk; because of 
the unusual clinical finding of the lesion with a mor-
phea-like appearance, and because our patient is 
still alive 1 year after the cutaneous recurrence.
          
Figure 3. Areas of sclerosis of the stroma with 
hypertrophic collagen bundles.
Figure 4. The positivity of the cytokeratins 7 and 
19.
Balzani et al:    Acta Dermatovenerol Croat
Cutaneous implantation metastasis of cholangiocarcinoma  2005;13(2):118-121
120
ACTA DERMATOVENEROLOGICA CROATICA
                               
References
1. Loew R, Dueber C, Schwarting A, Thelen M. Sub-
cutaneous implantation metastasis of a cholangi-
ocarcinoma of the bile duct after percutaneous 
transhepatic biliary drainage (PTBD). Eur Radiol 
1997;7:259-61.
2. Molnar W, Stockum AE. Relief of obstructive jaun-
dice through percutaneous transhepatic catheter 
– a new therapeutic method. AJR Am J Roentgenol 
1974;122:356-67.
3. Nakayama T, Ikeda A, Okuda K. Percutaneous 
transhepatic drainage of the biliary tract: tech-
nique and results in 104 cases. Gastroenterology 
1978;74:554-9.
4. Denning DA, Ellison EC, Carey LC. Preoperative 
percutaneous transhepatic biliary decompression 
lowers operative morbidity in patients with obstruc-
tive jaundice. Am J Surg 1981;141:61-5.
5. Carrasco CH, Zornoza J, Bechtel WJ. Malignant 
biliary obstruction: complications of percutaneous 
biliary drainage. Radiology 1984;152:343-6.
6. Gunther RW, Schild H, Thelen M. Percutane-
ous transhepatic biliary drainage: experience 
with 311 procedures. Cardiovasc Intervent Radiol 
1988;11:65-71. 
7. Hubens G. Port site metastasis: where are we at 
the beginning of the 21st century? Acta Chir Belg 
2002;102:230-7.
8. Casella G, Cacopardo E, Rovere G, Buda C, Cas-
cinu S, Baldini V. Cutaneous seeding after ultra-
sound-guided percutaneous ethanol injection for 
treatment of hepatocellular carcinoma. J Clin Ultras 
2001;29:354-8.
9. Eggermont A, Steller E, Parquet R. Local regional 
promotion of humour growth after abdominal sur-
gery is dominant over immunotherapy with inter-
leukin-2 and lymphokine activated killer cells. Can-
cer Detect Prev 1988;12:421-9.
10. Schwartz A. Cutaneous metastatic disease. J Am 
Acad Dermatol 1995;33:161-82.
Balzani et al:    Acta Dermatovenerol Croat
Cutaneous implantation metastasis of cholangiocarcinoma  2005;13(2):118-121
121
Sun, air and light with Nivea cream forever.
From the Nivea collection of Zlatko Puntijar (1927)
